NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE3926 Query DataSets for GSE3926
Status Public on Apr 15, 2010
Title Anthracycline treatment and resistance in four human cancer cell lines (HGU133A)
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Reliable clinical tests for predicting cancer chemotherapy response are not available and individual markers failed to correctly predict resistance against anticancer agents. We hypothesized that gene expression patterns attributable to chemotherapy-resistant cells can be used as a classification tool for chemoresistance and provide novel candidate genes involved in anthracycline resistance mechanisms. We contrasted the expression profiles of 4 different human tumor cell lines of gastric, pancreatic, colon and breast origin and of their counterparts resistant to the topoisomerase inhibitors daunorubicin or doxorubicin. We also profiled the sensitive parental cells treated with doxorubicin for 24h. We interrogated Affymetrix HGU133A and U95A arrays independently. We applied two independent methods for data normalization and used Prediction Analysis of Microarrays (PAM) for feature selection. In addition, we established data sets related to drug resistance by using a “virtual array” composed of features represented on both types of oligonucleotide arrays. We identified 71 candidate genes associated with doxorubicine/daunorubicine resistance. To validate the microarray data, we also analyzed the expression of 12 selected genes by quantitative RT-PCR or immunocytochemistry, respectively. While the comparison of drug-sensitive versus drug-resistant cells yields candidates associated with drug resistance, the 24h treatment of sensitive parental cells produced a distinct transcriptional profile related to short-term drug effects.
Keywords: cell type and treatment comparison
 
Overall design See Summary. Note: this series includes Affymetrix HGU133A chips (difference between resistance and treatment response).
 
Citation(s) 20010949
Submission date Dec 28, 2005
Last update date Aug 10, 2018
Contact name Balazs Györffy
E-mail(s) [email protected]
Organization name Hungarian Academy of Sciences
Street address Bókay 53
City Budapest
ZIP/Postal code H1083
Country Hungary
 
Platforms (1)
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array
Samples (12)
GSM89659 181_par (HG-U133A)
GSM89660 181_par_treatDb (HG-U133A)
GSM89661 181_RDb (HG-U133A)
This SubSeries is part of SuperSeries:
GSE3929 Anthracycline treatment and resistance in four human cancer cell lines
Relations
BioProject PRJNA94337

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE3926_RAW.tar 75.9 Mb (http)(custom) TAR (of CEL, TXT)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap